Skip to main content
Erschienen in: Journal of Urban Health 3/2019

05.06.2019

Willingness to Use Safe Consumption Spaces among Opioid Users at High Risk of Fentanyl Overdose in Baltimore, Providence, and Boston

verfasst von: Ju Nyeong Park, Susan G. Sherman, Saba Rouhani, Kenneth B. Morales, Michelle McKenzie, Sean T. Allen, Brandon D. L. Marshall, Traci C. Green

Erschienen in: Journal of Urban Health | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Safe consumption spaces (SCS) are evidence-based interventions that reduce drug-related morbidity and mortality operating in many countries. However, SCS are yet to be widely implemented in the USA despite the escalating overdose epidemic. The aim of this multi-city study was to identify the factors associated with willingness to use a SCS among people who use drugs (PWUD) in Baltimore, Providence, and Boston, stratified by injection drug use status. Our secondary aim was to characterize the anticipated barriers to accessing SCS if they were to be implemented in these cities. PWUD were invited to complete a cross-sectional survey in 2017. The analysis was restricted to 326 opioid users (i.e., heroin, fentanyl, and non-medical opioid pill use). The majority (77%) of participants expressed willingness to use a SCS (Baltimore, 78%; Providence, 68%; Boston. 84%). Most respondents were male (59%), older than 35 years (76%), non-white (64%), relied on public/semi-public settings to inject (60%), had a history of overdose (64%), and recently suspected fentanyl contamination of their drugs (73%). A quarter (26%) preferred drugs containing fentanyl. Among injectors, female gender, racial minority status, suspicion of drugs containing fentanyl, and drug use in public/semi-public settings were associated with higher willingness to use a SCS; prior arrest was associated with lower willingness. Among non-injectors, racial minority status, preference for fentanyl, and drug use in public/semi-public settings were associated with higher willingness, whereas recent overdose held a negative association. The most commonly anticipated barriers to accessing a SCS in the future were concerns around arrest (38%), privacy (34%), confidentiality/trust/safety (25%), and cost/time/transportation (16%). These data provide evidence of high SCS acceptability among high-risk PWUD in the USA, including those who prefer street fentanyl. As SCS are implemented in the USA, targeted engagement efforts may be required to reach individuals exposed to the criminal justice system.
Literatur
1.
Zurück zum Zitat Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths - United States, 2013-2017. MMWR Morb Mortal Wkly Rep. 2018;67(5152):1419–27.CrossRefPubMedPubMedCentral Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths - United States, 2013-2017. MMWR Morb Mortal Wkly Rep. 2018;67(5152):1419–27.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Drug Enforcement Administration. National Drug Threat Assessment. Washington D.C.: U.S. Department of Justice; 2017. Drug Enforcement Administration. National Drug Threat Assessment. Washington D.C.: U.S. Department of Justice; 2017.
3.
Zurück zum Zitat Sherman SG, Hunter K, Rouhani S. Safe drug consumption spaces: a strategy for Baltimore City. Baltimore, Maryland: Abell Foundation; 2017. Sherman SG, Hunter K, Rouhani S. Safe drug consumption spaces: a strategy for Baltimore City. Baltimore, Maryland: Abell Foundation; 2017.
4.
Zurück zum Zitat Potier C, Laprevote V, Dubois-Arber F, Cottencin O, Rolland B. Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014;145:48–68.CrossRefPubMed Potier C, Laprevote V, Dubois-Arber F, Cottencin O, Rolland B. Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014;145:48–68.CrossRefPubMed
5.
Zurück zum Zitat Barry CL, Sherman SG, McGinty EE. Language matters in combatting the opioid epidemic: safe consumption sites versus overdose prevention sites. Am J Public Health. 2018;108(9):1157–9.CrossRefPubMed Barry CL, Sherman SG, McGinty EE. Language matters in combatting the opioid epidemic: safe consumption sites versus overdose prevention sites. Am J Public Health. 2018;108(9):1157–9.CrossRefPubMed
6.
Zurück zum Zitat Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr T. Reduction in overdose mortality after the opening of North America’s first medically supervised safer injecting facility: a retrospective population-based study. Lancet. 2011;377(9775):1429–37.CrossRefPubMed Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr T. Reduction in overdose mortality after the opening of North America’s first medically supervised safer injecting facility: a retrospective population-based study. Lancet. 2011;377(9775):1429–37.CrossRefPubMed
7.
Zurück zum Zitat DeBeck K, Kerr T, Bird L, Zhang R, Marsh D, Tyndall M, et al. Injection drug use cessation and use of North America’s first medically supervised safer injecting facility. Drug Alcohol Depend. 2011;113(2–3):172–6.CrossRefPubMed DeBeck K, Kerr T, Bird L, Zhang R, Marsh D, Tyndall M, et al. Injection drug use cessation and use of North America’s first medically supervised safer injecting facility. Drug Alcohol Depend. 2011;113(2–3):172–6.CrossRefPubMed
8.
Zurück zum Zitat Vipler S, Hayashi K, Milloy MJ, Wood E, Nosova E, Kerr T, et al. Use of withdrawal management services among people who use illicit drugs in Vancouver, Canada. Subst Abuse Treat Prev Policy. 2018;13(1):27.CrossRefPubMedPubMedCentral Vipler S, Hayashi K, Milloy MJ, Wood E, Nosova E, Kerr T, et al. Use of withdrawal management services among people who use illicit drugs in Vancouver, Canada. Subst Abuse Treat Prev Policy. 2018;13(1):27.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Irwin A, Jozaghi E, Bluthenthal RN, Kral AH. A cost-benefit analysis of a potential supervised injection facility in San Francisco, California, USA. J Drug Issues. 0(0):0022042616679829. Irwin A, Jozaghi E, Bluthenthal RN, Kral AH. A cost-benefit analysis of a potential supervised injection facility in San Francisco, California, USA. J Drug Issues. 0(0):0022042616679829.
10.
Zurück zum Zitat Irwin A, Jozaghi E, Weir BW, Allen ST, Lindsay A, Sherman SG. Mitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facility. Harm Reduct J. 2017;14(1):29.CrossRefPubMedPubMedCentral Irwin A, Jozaghi E, Weir BW, Allen ST, Lindsay A, Sherman SG. Mitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facility. Harm Reduct J. 2017;14(1):29.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Mars SG, Ondocsin J, Ciccarone D. Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency. Harm Reduct J. 2018;15(1):26.CrossRefPubMedPubMedCentral Mars SG, Ondocsin J, Ciccarone D. Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency. Harm Reduct J. 2018;15(1):26.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Kral AH, Wenger L, Carpenter L, Wood E, Kerr T, Bourgois P. Acceptability of a safer injection facility among injection drug users in San Francisco. Drug Alcohol Depend. 2010;110(1–2):160–3.CrossRefPubMedPubMedCentral Kral AH, Wenger L, Carpenter L, Wood E, Kerr T, Bourgois P. Acceptability of a safer injection facility among injection drug users in San Francisco. Drug Alcohol Depend. 2010;110(1–2):160–3.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Bouvier BA, Elston B, Hadland SE, Green TC, Marshall BD. Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study. Harm Reduct J. 2017;14(1):13.CrossRefPubMedPubMedCentral Bouvier BA, Elston B, Hadland SE, Green TC, Marshall BD. Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study. Harm Reduct J. 2017;14(1):13.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Leon C, Cardoso L, Mackin S, Bock B, Gaeta JM. The willingness of people who inject drugs in Boston to use a supervised injection facility. Subst Abus. 2018;39(1):95–101.CrossRefPubMed Leon C, Cardoso L, Mackin S, Bock B, Gaeta JM. The willingness of people who inject drugs in Boston to use a supervised injection facility. Subst Abus. 2018;39(1):95–101.CrossRefPubMed
15.
Zurück zum Zitat Glick JL, Christensen T, Park JN, McKenzie M, Green TC, Sherman SG. Stakeholder perspectives on implementing fentanyl drug checking - results from a multi-site study. Accepted in Drug and Alcohol Dependence. Drug and Alcohol Dependence. In press. 194:527–532. Glick JL, Christensen T, Park JN, McKenzie M, Green TC, Sherman SG. Stakeholder perspectives on implementing fentanyl drug checking - results from a multi-site study. Accepted in Drug and Alcohol Dependence. Drug and Alcohol Dependence. In press. 194:527–532.
16.
Zurück zum Zitat Sherman SG, Morales K, Park JN, McKenzie M, Marshall BDL, Green TC. Feasibility of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence. Int J Drug Policy. 2019;68:46–53.CrossRefPubMed Sherman SG, Morales K, Park JN, McKenzie M, Marshall BDL, Green TC. Feasibility of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence. Int J Drug Policy. 2019;68:46–53.CrossRefPubMed
17.
Zurück zum Zitat Sherman SG, Park JN, Glick J, et al. FORECAST study summary report: Johns Hopkins Bloomberg School of Public Health: Baltimore; 2018. Sherman SG, Park JN, Glick J, et al. FORECAST study summary report: Johns Hopkins Bloomberg School of Public Health: Baltimore; 2018.
18.
Zurück zum Zitat Green TC, Park JN, Gilbert M, et al. A multi-site assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples. Under review. Green TC, Park JN, Gilbert M, et al. A multi-site assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples. Under review.
20.
Zurück zum Zitat Allen ST, Footer KHA, Galai N, Park JN, Silberzahn B, Sherman SG. Implementing targeted sampling: lessons learned from recruiting female sex workers in Baltimore, MD. J Urban Health. 2018. Allen ST, Footer KHA, Galai N, Park JN, Silberzahn B, Sherman SG. Implementing targeted sampling: lessons learned from recruiting female sex workers in Baltimore, MD. J Urban Health. 2018.
21.
Zurück zum Zitat Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of HIV risk among injecting drug users. Soc Sci Med. 2005;61(5):1026–44.CrossRefPubMed Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of HIV risk among injecting drug users. Soc Sci Med. 2005;61(5):1026–44.CrossRefPubMed
22.
Zurück zum Zitat Dasgupta N, Beletsky L, Ciccarone D. Opioid crisis: no easy fix to its social and economic determinants. Am J Public Health. 2018;108(2):182–6.CrossRefPubMedPubMedCentral Dasgupta N, Beletsky L, Ciccarone D. Opioid crisis: no easy fix to its social and economic determinants. Am J Public Health. 2018;108(2):182–6.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Macmadu A, Carroll JJ, Hadland SE, Green TC, Marshall BD. Prevalence and correlates of fentanyl-contaminated heroin exposure among young adults who use prescription opioids non-medically. Addict Behav. 2017;68:35–8.CrossRefPubMedPubMedCentral Macmadu A, Carroll JJ, Hadland SE, Green TC, Marshall BD. Prevalence and correlates of fentanyl-contaminated heroin exposure among young adults who use prescription opioids non-medically. Addict Behav. 2017;68:35–8.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Park JN, Weir BW, Allen ST, Chaulk P, Sherman SG. Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD. Harm Reduct J. 2018;15(1):34.CrossRefPubMedPubMedCentral Park JN, Weir BW, Allen ST, Chaulk P, Sherman SG. Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD. Harm Reduct J. 2018;15(1):34.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Hunter K, Park JN, Allen ST, Chaulk P, Frost T, Weir BW, et al. Safe and unsafe spaces: non-fatal overdose, arrest, and receptive syringe sharing among people who inject drugs in public and semi-public spaces in Baltimore City. Int J Drug Policy. 2018;57:25–31.CrossRefPubMedPubMedCentral Hunter K, Park JN, Allen ST, Chaulk P, Frost T, Weir BW, et al. Safe and unsafe spaces: non-fatal overdose, arrest, and receptive syringe sharing among people who inject drugs in public and semi-public spaces in Baltimore City. Int J Drug Policy. 2018;57:25–31.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Kral AH, Davidson PJ. Addressing the nation’s opioid epidemic: lessons from an unsanctioned supervised injection site in the U.S. Am J Prev Med. 2017;53(6):919–22.CrossRefPubMed Kral AH, Davidson PJ. Addressing the nation’s opioid epidemic: lessons from an unsanctioned supervised injection site in the U.S. Am J Prev Med. 2017;53(6):919–22.CrossRefPubMed
28.
Zurück zum Zitat Wood E, Kerr T, Small W, Li K, Marsh DC, Montaner JS, et al. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. CMAJ. 2004;171(7):731–4.CrossRefPubMedPubMedCentral Wood E, Kerr T, Small W, Li K, Marsh DC, Montaner JS, et al. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. CMAJ. 2004;171(7):731–4.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Stoltz JA, Wood E, Small W, Li K, Tyndall M, Montaner J, et al. Changes in injecting practices associated with the use of a medically supervised safer injection facility. J Public Health (Oxf). 2007;29(1):35–9.CrossRef Stoltz JA, Wood E, Small W, Li K, Tyndall M, Montaner J, et al. Changes in injecting practices associated with the use of a medically supervised safer injection facility. J Public Health (Oxf). 2007;29(1):35–9.CrossRef
30.
Zurück zum Zitat Mattson CL, O’Donnell J, Kariisa M, Seth P, Scholl L, Gladden RM. Opportunities to prevent overdose deaths involving prescription and illicit opioids, 11 states, July 2016-June 2017. MMWR Morb Mortal Wkly Rep. 2018;67(34):945–51.CrossRefPubMedPubMedCentral Mattson CL, O’Donnell J, Kariisa M, Seth P, Scholl L, Gladden RM. Opportunities to prevent overdose deaths involving prescription and illicit opioids, 11 states, July 2016-June 2017. MMWR Morb Mortal Wkly Rep. 2018;67(34):945–51.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Krieger MS, Yedinak JL, Buxton JA, Lysyshyn M, Bernstein E, Rich JD, et al. High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduct J. 2018;15(1):7.CrossRefPubMedPubMedCentral Krieger MS, Yedinak JL, Buxton JA, Lysyshyn M, Bernstein E, Rich JD, et al. High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduct J. 2018;15(1):7.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Sutter A, Curtis M, Frost T. Public drug use in eight U.S. cities: health risks and other factors associated with place of drug use. Int J Drug Policy. 2019;64:62–9.CrossRefPubMed Sutter A, Curtis M, Frost T. Public drug use in eight U.S. cities: health risks and other factors associated with place of drug use. Int J Drug Policy. 2019;64:62–9.CrossRefPubMed
33.
Zurück zum Zitat Collins SE, Malone DK, Clifasefi SL, Ginzler JA, Garner MD, Burlingham B, et al. Project-based Housing First for chronically homeless individuals with alcohol problems: within-subjects analyses of 2-year alcohol trajectories. Am J Public Health. 2012;102(3):511–9.CrossRefPubMedPubMedCentral Collins SE, Malone DK, Clifasefi SL, Ginzler JA, Garner MD, Burlingham B, et al. Project-based Housing First for chronically homeless individuals with alcohol problems: within-subjects analyses of 2-year alcohol trajectories. Am J Public Health. 2012;102(3):511–9.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Tsai J, Mares AS, Rosenheck RA. A multi-site comparison of supported housing for chronically homeless adults: “housing first” versus “residential treatment first”. Psychol Serv. 2010;7(4):219–32.CrossRefPubMedPubMedCentral Tsai J, Mares AS, Rosenheck RA. A multi-site comparison of supported housing for chronically homeless adults: “housing first” versus “residential treatment first”. Psychol Serv. 2010;7(4):219–32.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat O’Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM. Deaths involving fentanyl, fentanyl analogs, and U-47700 - 10 states, July-December 2016. MMWR Morb Mortal Wkly Rep. 2017;66(43):1197–202.CrossRefPubMedPubMedCentral O’Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM. Deaths involving fentanyl, fentanyl analogs, and U-47700 - 10 states, July-December 2016. MMWR Morb Mortal Wkly Rep. 2017;66(43):1197–202.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Burris S, Blankenship KM, Donoghoe M, et al. Addressing the “risk environment” for injection drug users: the mysterious case of the missing cop. Milbank Q. 2004;82(1):125–56.CrossRefPubMedPubMedCentral Burris S, Blankenship KM, Donoghoe M, et al. Addressing the “risk environment” for injection drug users: the mysterious case of the missing cop. Milbank Q. 2004;82(1):125–56.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Binswanger IA, Stern MF, Deyo RA, Heagerty PJ, Cheadle A, Elmore JG, et al. Release from prison--a high risk of death for former inmates. N Engl J Med. 2007;356(2):157–65.CrossRefPubMedPubMedCentral Binswanger IA, Stern MF, Deyo RA, Heagerty PJ, Cheadle A, Elmore JG, et al. Release from prison--a high risk of death for former inmates. N Engl J Med. 2007;356(2):157–65.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Beletsky L, Cochrane J, Sawyer AL, et al. Police encounters among needle exchange clients in Baltimore: drug law enforcement as a structural determinant of health. 20150808 DCOM- 20151030 (1541–0048 (Electronic)). 2015;105(9):1872–9. Beletsky L, Cochrane J, Sawyer AL, et al. Police encounters among needle exchange clients in Baltimore: drug law enforcement as a structural determinant of health. 20150808 DCOM- 20151030 (1541–0048 (Electronic)). 2015;105(9):1872–9.
39.
Zurück zum Zitat Beletsky L, Grau LE, White E, Bowman S, Heimer R. The roles of law, client race and program visibility in shaping police interference with the operation of US syringe exchange programs. Addiction. 2011;106(2):357–65.CrossRefPubMed Beletsky L, Grau LE, White E, Bowman S, Heimer R. The roles of law, client race and program visibility in shaping police interference with the operation of US syringe exchange programs. Addiction. 2011;106(2):357–65.CrossRefPubMed
40.
Zurück zum Zitat Alexander M. The New Jim Crow: Mass Incarceration in the Age of Colorblindness. New York, NY: The New Press; 2012. Alexander M. The New Jim Crow: Mass Incarceration in the Age of Colorblindness. New York, NY: The New Press; 2012.
43.
Zurück zum Zitat Csete J, Kamarulzaman A, Kazatchkine M, Altice F, Balicki M, Buxton J, et al. Public health and international drug policy. Lancet. 2016;387(10026):1427–80.CrossRefPubMedPubMedCentral Csete J, Kamarulzaman A, Kazatchkine M, Altice F, Balicki M, Buxton J, et al. Public health and international drug policy. Lancet. 2016;387(10026):1427–80.CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Kerr T, MacPherson D, Wood E. Establishing North America’s first safer injection facility: lessons from the Vancouver experience. In: Stevens A, editor. Crossing Frontiers: International Developments in the Treatment of Drug Dependence. Brighton: Pavilion Publishing; 2008. Kerr T, MacPherson D, Wood E. Establishing North America’s first safer injection facility: lessons from the Vancouver experience. In: Stevens A, editor. Crossing Frontiers: International Developments in the Treatment of Drug Dependence. Brighton: Pavilion Publishing; 2008.
45.
Zurück zum Zitat Anoro M, Ilundain E, Santisteban O. Barcelona’s safer injection facility-EVA: a harm reduction program lacking official support. J Drug Issues. 2003;33(3):689–711.CrossRef Anoro M, Ilundain E, Santisteban O. Barcelona’s safer injection facility-EVA: a harm reduction program lacking official support. J Drug Issues. 2003;33(3):689–711.CrossRef
Metadaten
Titel
Willingness to Use Safe Consumption Spaces among Opioid Users at High Risk of Fentanyl Overdose in Baltimore, Providence, and Boston
verfasst von
Ju Nyeong Park
Susan G. Sherman
Saba Rouhani
Kenneth B. Morales
Michelle McKenzie
Sean T. Allen
Brandon D. L. Marshall
Traci C. Green
Publikationsdatum
05.06.2019
Verlag
Springer US
Erschienen in
Journal of Urban Health / Ausgabe 3/2019
Print ISSN: 1099-3460
Elektronische ISSN: 1468-2869
DOI
https://doi.org/10.1007/s11524-019-00365-1

Weitere Artikel der Ausgabe 3/2019

Journal of Urban Health 3/2019 Zur Ausgabe